Viridian Therapeutics, Inc.\DE (VRDN) EBIT Margin (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) recorded EBIT Margin of -44460.56% in Q2 2026, up 97895.44 percentage points from -142356.00% a year earlier and up 37928.80 percentage points from the prior quarter.
Viridian Therapeutics, Inc.\DE (VRDN) EBIT Margin (2013 - 2026) Analysis & Trends
On a TTM basis, Viridian Therapeutics, Inc.\DE's EBIT Margin came in at -569.68% as of Jun 30, 2026, up 121261.46 percentage points year-over-year; for FY2025, it was -512.91%, up 98505.30 percentage points from FY2024.
- Annual EBIT Margin has a five-year change of +9999.47 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at -99018.21% in FY2024 (-17983.18 pp), -81035.03% in FY2023 (-73455.80 pp), -7579.23% in FY2022 (-4888.45 pp) and -2690.79% in FY2021 (+7821.59 pp).
- Quarterly EBIT Margin has ranged from -142356.00% in Q2 2025 to -56.70% in Q3 2025 over the past five years.
- On a year-over-year basis, EBIT Margin has increased for four consecutive quarters, with an average year-over-year change of +16051.95 percentage points over the last eight quarters.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 154184.82 percentage points in Q4 2021, against a drop of 70777.95 percentage points in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -82389.36% (Q1 2026), -92991.67% (Q4 2025) and -56.70% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Viridian Therapeutics, Inc.\DE | 2.33 Bn | 2.33 Bn | - | -44,460.56% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -44,460.56% |
| Mar 31, 2026 | -82,389.36% |
| Dec 31, 2025 | -92,991.67% |
| Sep 30, 2025 | -56.70% |
| Jun 30, 2025 | -142,356.00% |
| Mar 31, 2025 | -130,369.44% |
| Dec 31, 2024 | -121,488.89% |
| Sep 30, 2024 | -97,069.77% |
| Jun 30, 2024 | -100,259.72% |
| Mar 31, 2024 | -77,634.72% |
| Dec 31, 2023 | -99,275.00% |
| Sep 30, 2023 | -71,144.44% |
| Jun 30, 2023 | -82,326.39% |
| Mar 31, 2023 | -73,952.04% |
| Dec 31, 2022 | -46,729.52% |
| Sep 30, 2022 | -2,492.47% |
| Jun 30, 2022 | -11,548.44% |
| Mar 31, 2022 | -11,985.65% |
| Dec 31, 2021 | -13,589.25% |
| Sep 30, 2021 | -6,795.19% |
Viridian Therapeutics, Inc.\DE EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();